Benjamin J Sieniewicz1, Jonathan M Behar2, Justin Gould2, Simon Claridge2, Bradley Porter2, Baldeep S Sidhu2, Steve Niederer3, Tim R Betts4, David Webster4, Simon James5, Andrew J Turley5, Christopher A Rinaldi2. 1. Division of Imaging Sciences and Biomedical Engineering, King's College London, United Kingdom; Cardiology Department, Guys and St. Thomas' National Health Service (NHS) Foundation Trust, London, United Kingdom. Electronic address: benjamin.sieniewicz@kcl.ac.uk. 2. Division of Imaging Sciences and Biomedical Engineering, King's College London, United Kingdom; Cardiology Department, Guys and St. Thomas' National Health Service (NHS) Foundation Trust, London, United Kingdom. 3. Division of Imaging Sciences and Biomedical Engineering, King's College London, United Kingdom. 4. Cardiology Department, The John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom. 5. Cardiology Department, The James Cook Hospital, South Tees Hospitals NHS Foundation Trust, Middlesbrough, United Kingdom.
Abstract
OBJECTIVES: This study hypothesized that guided implants, in which the optimal left ventricular endocardial (LVENDO) pacing location was identified and targeted, would improve acute markers of contractility and chronic markers of cardiac resynchronization (CRT) response. BACKGROUND: Biventricular endocardial (BiVENDO) pacing may offer a potential benefit over standard CRT; however, the optimal LVENDO pacing site is highly variable. Indiscriminately delivered BiVENDO pacing is associated with a reverse remodeling response rate of between 40% and 60%. METHODS: Registry of centers implanting a wireless, LVENDO pacing system (WiSE-CRT System, EBR Systems, Sunnyvale, California); John Radcliffe Hospital (Oxford, United Kingdom), Guy's and St. Thomas' Hospital (London, United Kingdom), and The James Cook University Hospital (Middlesbrough, United Kingdom). Centers used a combination of preprocedural imaging and electroanatomical mapping the identify the optimal LVENDO site. RESULTS: A total of 26 patients across the 3 centers underwent a guided implant. Patients were predominantly male with a mean age of 68.8 ± 8.4 years, the mean LV ejection fraction was 34.2 ± 7.8%. The mean QRS duration was 163.8 ± 26.7 ms, and 30.8% of patients had an ischemic etiology. It proved technically feasible to selectively target and deploy the pacing electrode in a chosen endocardial segment in almost all cases, with a similar complication rate to that observed during indiscriminate BiVENDO. Ninety percent of patients met the definition of echocardiographic responder. Reverse remodeling was observed in 71%. CONCLUSIONS: Guided endocardial implants were associated with a higher degree of chronic LV remodeling compared with historical nonguided approaches.
OBJECTIVES: This study hypothesized that guided implants, in which the optimal left ventricular endocardial (LVENDO) pacing location was identified and targeted, would improve acute markers of contractility and chronic markers of cardiac resynchronization (CRT) response. BACKGROUND: Biventricular endocardial (BiVENDO) pacing may offer a potential benefit over standard CRT; however, the optimal LVENDO pacing site is highly variable. Indiscriminately delivered BiVENDO pacing is associated with a reverse remodeling response rate of between 40% and 60%. METHODS: Registry of centers implanting a wireless, LVENDO pacing system (WiSE-CRT System, EBR Systems, Sunnyvale, California); John Radcliffe Hospital (Oxford, United Kingdom), Guy's and St. Thomas' Hospital (London, United Kingdom), and The James Cook University Hospital (Middlesbrough, United Kingdom). Centers used a combination of preprocedural imaging and electroanatomical mapping the identify the optimal LVENDO site. RESULTS: A total of 26 patients across the 3 centers underwent a guided implant. Patients were predominantly male with a mean age of 68.8 ± 8.4 years, the mean LV ejection fraction was 34.2 ± 7.8%. The mean QRS duration was 163.8 ± 26.7 ms, and 30.8% of patients had an ischemic etiology. It proved technically feasible to selectively target and deploy the pacing electrode in a chosen endocardial segment in almost all cases, with a similar complication rate to that observed during indiscriminate BiVENDO. Ninety percent of patients met the definition of echocardiographic responder. Reverse remodeling was observed in 71%. CONCLUSIONS: Guided endocardial implants were associated with a higher degree of chronic LV remodeling compared with historical nonguided approaches.
Authors: Nadeev Wijesuriya; Mark K Elliott; Vishal Mehta; Baldeep S Sidhu; Marina Strocchi; Jonathan M Behar; Steven Niederer; Christopher A Rinaldi Journal: Front Physiol Date: 2022-06-06 Impact factor: 4.755
Authors: Benjamin J Sieniewicz; Timothy R Betts; Simon James; Andrew Turley; Christian Butter; Martin Seifert; Lucas V A Boersma; Sam Riahi; Petr Neuzil; Mauro Biffi; Igor Diemberger; Pasquale Vergara; Martin Arnold; David T Keane; Pascal Defaye; Jean-Claude Deharo; Anthony Chow; Richard Schilling; Jonathan Behar; Christopher A Rinaldi Journal: Heart Rhythm Date: 2020-03-09 Impact factor: 6.343
Authors: Hans Thijs van den Broek; Steven Wenker; Rutger van de Leur; Pieter A Doevendans; Steven A J Chamuleau; Frebus J van Slochteren; René van Es Journal: J Cardiovasc Transl Res Date: 2019-07-23 Impact factor: 4.132
Authors: Baldeep S Sidhu; Justin Gould; Mark K Elliott; Vishal Mehta; Steven Niederer; Christopher A Rinaldi Journal: Arrhythm Electrophysiol Rev Date: 2021-04
Authors: Yanrong Yin; Konstantinos Dimopoulos; Eriko Shimada; Karen Lascelles; Samuel Griffiths; Tom Wong; Michael A Gatzoulis; Sonya V Babu-Narayan; Wei Li Journal: J Am Heart Assoc Date: 2019-10-28 Impact factor: 5.501